The trademark SIDEREMIL VITA was filed by ENFARMA S.r.l., a corporation established under the laws of the Italian Republic (the "Applicant"). The application was published for oppositions on April 23, 2018, and received one opposition filed on June 12, 2018 by PHARMANUTRA S.P.A. on Likelihood of confusion. the opponent was represented by HOFFMANN EITLE S.R.L.
The application was filed in Italian, and Italian was also language of all opposition proceedings (English was selected as the second language).
The Appeal with reference B R1254/2020-1 was Opposition rejected according to Article 8(1)(b) EUTMR with decision issued on December 14, 2021 by the EUIPO. The Opposition with reference B 003054585 was rejected according to Article 8(1)(b) EUTMR with decision issued on April 24, 2020 by the EUIPO.